IHH Healthcare Berhad
VC Fund
Kuala Lumpur, Malaysia
IHH Healthcare Berhad ("IHH or the Group") is a leading international provider of premium healthcare services in markets where the demand for quality healthcare is growing rapidly – specifically in Asia and Central & Eastern Europe, the Middle East and North Africa ("CEEMENA"). We are the world's second-largest listedhealthcare operator by market capitalisation and are today the leading player in our home markets of Singapore, Malaysia and Turkey, and the key markets of the People's Republic of China ("China"), Hong Kong and India. We are also present in Brunei, Vietnam, United Arab Emirates ("the UAE"), Macedonia and Iraq.
- Total investments:
- 6
- Last investment:
- Lead investor:
- 67%
Last updated:
For AI agents: llms.txt
Industries IHH Healthcare Berhad invests in
Stages IHH Healthcare Berhad invests in
Countries IHH Healthcare Berhad invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Series A
- $15M–$20M
Investment Focus
Industry
- Health Care 5 (83%)
- Medical 3 (50%)
- mHealth 1 (17%)
- Genetics 1 (17%)
- Hospital 1 (17%)
Stage
- Series A 2 (33%)
- Corporate Round 2 (33%)
- Series B 1 (17%)
- Series C 1 (17%)
Country
- Singapore 3 (50%)
- United States 2 (33%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Kelvin Loh
Managing Director and CEO
|
Managing Director and CEO | Total investments: 1 | Find email | |
Elizabeth Han
AVP
|
AVP | Total investments: 0 | Find email | |
Lincoln Chee Wang Jin
Greater China CEO
|
Greater China CEO | Total investments: 1 | Find email | |
Satoshi Tanaka
Director
|
Director | Total investments: 0 | Find email | |
Tan See Leng
MD & CEO
|
MD & CEO | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| TibaRay’s mission is to bring the hope of a cure to patients with cancer by creating revolutionary, ultra-fast, and ultra-precise technologies that advance the accuracy and effectiveness of cancer diagnosis and treatment, ultimately improving patient outcomes and quality of life. | Corporate Round / Jan 29, 2026 | ||
| Intellect is a modern-day mental health company with a mission to make mental healthcare & wellbeing support accessible for everyone. Today, Intellect is the largest and fastest growing mental health tech company in Asia, and serves over 2 million members and leading organisations globally through our mental health platform. Intellect wasalso selected as one of Google’s Best Apps of 2020. Intellect is backed by leading investors including Insignia Ventures Partners, Y Combinator, and an extensive list of family offices, big tech executives & renowned angel investors. | Corporate Round / Mar 15, 2023 | ||
| Doctor Anywhere is a Singapore-based telehealth company that provides on demand healthcare solutions to help you lead happier, healthier lives. Their digital platform gives you quick access to health and wellness solutions, wherever you are. Their platform makes healthcare simple, seamless and convenient, and is optimised to help you manage yourhealth in a way that best suits your lifestyle needs. With technology, better health outcomes are more achievable than ever before. They recognize modern-day struggles and are dedicated to improving healthcare services to suit our evolving lifestyle preferences. | $38.8M / Series C / Dec 21, 2022 | ||
| Us2.ai develops software and digital tools for echocardiography using artificial intelligence. It provides online solutions to simplify access of results of echo analysis and heart ultrasound. Us2.ai is based in Singapore. | $15M / Series A / Apr 14, 2022 | ||
| Doctor Anywhere is a Singapore-based telehealth company that provides on demand healthcare solutions to help you lead happier, healthier lives. Their digital platform gives you quick access to health and wellness solutions, wherever you are. Their platform makes healthcare simple, seamless and convenient, and is optimised to help you manage yourhealth in a way that best suits your lifestyle needs. With technology, better health outcomes are more achievable than ever before. They recognize modern-day struggles and are dedicated to improving healthcare services to suit our evolving lifestyle preferences. | $27M / Series B / Mar 31, 2020 | ||
| Lucence Health is a liquid biopsy company detecting the hallmarks of cancer for earlier detection and targeted treatment. | $20M / Series A / Nov 20, 2019 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does IHH Healthcare Berhad invest in?
IHH Healthcare Berhad invests primarily in Health Care, Medical and mHealth startups, most often at Series A and Corporate Round stage. Most of the 6 investments tracked by Shizune back companies in Singapore. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does IHH Healthcare Berhad invest in?
IHH Healthcare Berhad typically joins rounds of $15M–$20M at Series A. These are whole funding-round sizes, not IHH Healthcare Berhad's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds IHH Healthcare Berhad took part in.
How do I contact IHH Healthcare Berhad?
Public channels for IHH Healthcare Berhad include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at IHH Healthcare Berhad?
The team at IHH Healthcare Berhad includes Kelvin Loh (Managing Director and CEO), Elizabeth Han (AVP) and Lincoln Chee Wang Jin (Greater China CEO). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
